Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
about
Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMIOxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological roleOxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosisAntioxidant and inflammatory aspects of lipoprotein-associated phospholipase A₂ (Lp-PLA₂): a reviewHuman Genetics and the Causal Role of Lipoprotein(a) for Various DiseasesGeneration and biological activities of oxidized phospholipidsThe role of oxidized phospholipids in atherosclerosis.Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literaturePro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).Low apolipoprotein M serum levels correlate with Systemic lupus erythematosus disease activity and apolipoprotein M gene polymorphisms with LupusLp-PLA2 Inhibition-The Atherosclerosis Panacea?Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish.Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate dietRegulation of platelet function by class B scavenger receptors in hyperlipidemiaLipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectorisImaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directionsIntegrative Treatments to Reduce Risk for Cardiovascular DiseaseAre Additional Lipid Measures Useful?Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study.The Dynamics of Oxidized LDL during Atherogenesis.Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects.Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese populationGenetic polymorphisms influence runners' responses to the dietary ingestion of antioxidant supplementation based on pequi oil (Caryocar brasiliense Camb.): a before-after study.Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.Systematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and AtherosclerosisHeritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.Carotid Intima-Media Thickness in Asymptomatic Subjects With Low Lipoprotein(a) Levels.Increased LDL susceptibility to oxidation accelerates future carotid artery atherosclerosisOxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction.In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probesModulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis).Determination of phospholipase activity of PAF acetylhydrolaseEmerging applications for zebrafish as a model organism to study oxidative mechanisms and their roles in inflammation and vascular accumulation of oxidized lipidsMechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a).Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesionsA Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis.Adaptive immunity in atherogenesis: new insights and therapeutic approaches.
P2860
Q24649961-46592225-6028-4D61-8CC5-2D744BE9A94BQ26747100-2CE7A536-B822-4900-8B46-0748D97F375EQ26822962-BDC5CAB9-B894-4A7C-A708-653FFA5D757EQ26991853-738CDEC8-6127-469A-83A5-515D6CBBE766Q28079294-04FF25CD-D9AD-43D9-A9A4-C8EE468000EAQ28389691-223A659A-F7C8-4D2F-A88E-CE782455357DQ30436606-B21B137A-70AC-4117-BB7D-405A6437435FQ33536648-8077BDCF-EA3F-4250-8CE5-925227E350CDQ33561072-A7CBB650-0C94-4025-A8C6-F1B0926A5392Q33644604-59B5DF10-0A69-4885-B82B-2520686E7962Q33664272-6A6CA71E-637C-4869-8774-81BB5E328640Q33709903-26777F1D-ECEC-4065-8F56-64763613300AQ34037051-EF1B33B7-206B-4E5B-8DE6-0D6AF8795286Q34188087-E9D29237-F197-4561-82B2-1B776F9FCBE5Q34397435-5516970F-8FC9-4B7B-98F1-591495CFA62AQ34504402-ABF00766-CDFA-4F04-8A82-1729773B0CA7Q34518372-BF550B43-D94F-4322-9A04-EF1166859810Q34730309-7BDCC23B-DD9C-4003-B853-75C3DE987732Q34730419-048133EA-B2F0-461C-8EF6-286A300E6B14Q34955900-DF573C5B-10DD-4E77-A55E-87EB7EA28451Q35024665-DDDE8187-DA5C-4F75-A79C-BC86C8E70353Q35141782-1E9AE4FE-D360-47DD-A0ED-5F8B88BDA5BCQ35169770-C70AB5C0-BA61-4B18-9BBF-BDAF86F3CA51Q35401476-579C78CA-2A70-4B3E-822A-990F540E68D8Q35592510-6A8B07A3-B780-4D63-AB83-A3ACE309229EQ35737842-57B5B419-CCE4-4DC3-B4A4-4EFA76CACBFAQ35764402-5D371BE0-1CF0-48FE-A78F-6E64EEE838ECQ35789087-C98984DA-7A6F-466D-8086-42338BD6F3EFQ35872497-D95E8A48-954E-4BD6-B44F-FD0ECE61771FQ35883396-11F875F3-91C5-42C7-A524-D2D8968F7477Q35905628-2EFCB5D7-7940-445A-AAFF-85C89EC320DDQ35905632-88AB13C6-8E21-4358-B8B0-DDDB7A393D91Q36145180-9C3F4CC3-1733-437C-9B15-7A1D7687FBCBQ36148940-6950BC3E-DF37-4291-888B-442989008D3FQ36240691-3863217E-3D40-47AE-9BCC-23DE62CA63FFQ36252515-7FFECD20-DF06-45BE-9C5A-4BCEC33F37C5Q36307282-1BF29C72-A8CF-4BCC-AF34-CC2360555A1EQ36387263-98D67103-138F-4886-A9DD-814BABE05EF0Q36469043-ADB556B8-C628-4471-A7E1-C2EC6E823A73Q36497196-88679C95-A2AF-4093-BB60-B45AAD66F86D
P2860
Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Oxidized phospholipids, lipopr ...... esults from the Bruneck study.
@ast
Oxidized phospholipids, lipopr ...... esults from the Bruneck study.
@en
Oxidized phospholipids, lipopr ...... esults from the Bruneck study.
@nl
type
label
Oxidized phospholipids, lipopr ...... esults from the Bruneck study.
@ast
Oxidized phospholipids, lipopr ...... esults from the Bruneck study.
@en
Oxidized phospholipids, lipopr ...... esults from the Bruneck study.
@nl
prefLabel
Oxidized phospholipids, lipopr ...... esults from the Bruneck study.
@ast
Oxidized phospholipids, lipopr ...... esults from the Bruneck study.
@en
Oxidized phospholipids, lipopr ...... esults from the Bruneck study.
@nl
P2093
P50
P921
P1476
Oxidized phospholipids, lipopr ...... esults from the Bruneck study.
@en
P2093
Brigitte Viehweider
Christian J Wiedermann
Johann Willeit
Martin Oberhollenzer
Sabine Oberthaler
Stefan Kiechl
P304
P356
10.1161/ATVBAHA.107.145805
P407
P577
2007-05-31T00:00:00Z